FindMyKOL

Shant Manoushagian, MD

Basic profile

Florida State University

ORCIDNone on fileNPI↗
✓ Itemized record
RegionFort Myers, FL · SoutheastSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLEmergingFindMyKOL type: RegionalLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Shant Manoushagian is a Cardiology physician affiliated with Florida State University. OpenAlex indexes 21 publications with 431 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
21publications

Publications indexed by OpenAlex. Counts exclude supporting files.

431citations

Citations across these publications.

6h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
12companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

All 27 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    89.6%
    Beta blocker34%
    Metoprolol Succinate68%Metoprolol Tartrate17%Carvedilol14%
    Part D<11 patients
    Statin34%
    Atorvastatin Calcium79%Simvastatin21%
    Part D<11 patients

    + 3 more classes in this area

  • Blood & clotting

    10.4%
    P2Y12 inhibitor5.6%
    Clopidogrel100%
    Part D<11 patients
    Factor Xa inhibitor4.9%
    Eliquis100%
    Part D<11 patients
Where care is delivered (Part B)90.5% facility · 9.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

All 21 publications: search, sort and filter.Explore →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”